These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 174206)

  • 1. [Procedure for inscription of drugs on the Social Security reimbursement list].
    Coudurier P
    Sem Hop; 1975 Nov; 51(45):Suppl 195-8. PubMed ID: 174206
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of drugs in man and animals.
    Uvarov O
    Proc R Soc Med; 1968 Jun; 61(6):569-74. PubMed ID: 4873871
    [No Abstract]   [Full Text] [Related]  

  • 3. [Description of unused drugs collected in pharmacies in the Puy-de-Dôme region in France].
    Marchiset-Ferlay N; Gerbaud L; Sauvant MP; Jaffeux P; Manhes G; Leblanc N; Coste F; Andriollo O
    Rev Epidemiol Sante Publique; 2001 Dec; 49(6):551-8. PubMed ID: 11845104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real medical benefit assessed by indirect comparison.
    Falissard B; Zylberman M; Cucherat M; Izard V; Meyer F
    Therapie; 2009; 64(3):225-32. PubMed ID: 19671436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drugs supply disruption].
    Arzalier-Daret S
    Ann Fr Anesth Reanim; 2013 Mar; 32(3):127-9. PubMed ID: 23414926
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnostic tests approved by the Ministry of Health and Welfare].
    Rinsho Byori; 2005 Jul; 53(7):668-9. PubMed ID: 16104537
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the medical value of a drug. A necessity for the Transparency Commission].
    Avouac B
    Therapie; 1992; 47(1):9-16. PubMed ID: 1523604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Policies concerning pharmaceutical prices and reimbursement in Mexico, Organization for Co-operation and Economic Development. 2007].
    Moïse P; Docteur E
    Salud Publica Mex; 2008; 50 Suppl 4():S504-10. PubMed ID: 19082262
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tomorrow's drugs].
    Legrain M
    Cah Sociol Demogr Med; 1983; 23(2):149-59. PubMed ID: 6883157
    [No Abstract]   [Full Text] [Related]  

  • 10. [The cost of innovative drugs].
    Reggio S
    Recenti Prog Med; 1999; 90(7-8):371-2. PubMed ID: 10429514
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussion.
    Palylyk-Colwell E; Jamali F; Dryden W; Friesen E; Koven S; Mohamed I; Osmond B; Alessi-Severini S; Sheldon L; Sheldon R; Tam Y; Tsuyuki R; Zhanel G
    J Pharm Pharm Sci; 1998; 1(1):2-7. PubMed ID: 10942966
    [No Abstract]   [Full Text] [Related]  

  • 12. [30 years in the history of drugs and drug therapy].
    Taboulet F
    Cah Sociol Demogr Med; 1994; 34(4):325-52. PubMed ID: 7736313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QUAD routes out inferior drugs.
    Can Hosp; 1973 May; 50(5):58-9. PubMed ID: 4779804
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: MAC.
    Am Fam Physician; 1975 Mar; 11(3):67, 69. PubMed ID: 1114938
    [No Abstract]   [Full Text] [Related]  

  • 15. Pricing and reimbursement of in-patent drugs in seven European countries: a comparative analysis.
    Garattini L; Cornago D; De Compadri P
    Health Policy; 2007 Aug; 82(3):330-9. PubMed ID: 17125881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equitable access to biomedical advances: getting beyond the rights impasse.
    Mariner WK
    Conn Law Rev; 1989; 21(3):571-603. PubMed ID: 11650430
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ranking the efficacy of drugs--a question of "class"? It is difficult to determine equivalency of two different treatments].
    Liedholm H; Linné AB
    Lakartidningen; 2002 Sep; 99(36):3492-4, 3497-9, 3502. PubMed ID: 12362748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [70 years of the State Institute for Drug Control].
    Drábek P; Hanzlícek Z
    Cesk Farm; 1988 Sep; 37(7):331-5. PubMed ID: 3058327
    [No Abstract]   [Full Text] [Related]  

  • 19. 3. Drug regulations in Switzerland and their application.
    Hippenmeier F
    Bull Parenter Drug Assoc; 1974; 28(4):167-73. PubMed ID: 4855448
    [No Abstract]   [Full Text] [Related]  

  • 20. Should the patent system for new medicines be abolished?
    DiMasi JA; Grabowski HG
    Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.